OtherCardiovascular
The effects of a novel cardioselective ATP-sensitive potassium channel antagonist, HMR 1402, on suceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies
George E. Billman, Melanie S. Houle, Heinrich C. Englert and Heinz Gogelein
Journal of Pharmacology and Experimental Therapeutics January 13, 2004, DOI: https://doi.org/10.1124/jpet.103.061416
George E. Billman
Melanie S. Houle
Heinrich C. Englert
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherCardiovascular
The effects of a novel cardioselective ATP-sensitive potassium channel antagonist, HMR 1402, on suceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies
George E. Billman, Melanie S. Houle, Heinrich C. Englert and Heinz Gogelein
Journal of Pharmacology and Experimental Therapeutics January 13, 2004, DOI: https://doi.org/10.1124/jpet.103.061416
OtherCardiovascular
The effects of a novel cardioselective ATP-sensitive potassium channel antagonist, HMR 1402, on suceptibility to ventricular fibrillation induced by myocardial ischemia: in vitro and in vivo studies
George E. Billman, Melanie S. Houle, Heinrich C. Englert and Heinz Gogelein
Journal of Pharmacology and Experimental Therapeutics January 13, 2004, DOI: https://doi.org/10.1124/jpet.103.061416
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement